Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?

Biomarkers, or more specifically molecular markers, can detect biochemical changes associated with disease processes and drug effects before histopathological and pathophysiological changes occur. Multiplexing technologies such as high-performance liquid chromatography/mass spectrometry (LC-MS) allo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Christians, Uwe, Klepacki, Jacek, Shokati, Touraj, Klawitter, Jost, Klawitter, Jelena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640576/
https://ncbi.nlm.nih.gov/pubmed/23645936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.microc.2012.02.011
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak